To combat an infection pandemic we urgently need to modernize and upgrade our diagnostics. CONVAT will provide powerful and innovative technology, based on nanophotonic sensors, for the rapid and ultransensitive detection of coronaviruses at the point of care. The CONVAT biosensor will be developed and applied for the direct detection of SARS-CoV-2 in respiratory fluids in less than 30 minutes assay.

The nanobiosensor could be used for early diagnosis of COVID-19 and efficient population screening. Furthermore, a new biosensor will be implemented for the monitoring of coronaviruses in animal reservoirs (bats and rodents), as a surveillance strategy to prevent outbreaks of future pandemics.